The protien Igf-1 Des1

(Click here to read our disclaimer)

(Click here to view this product in our store)

Igf-1 Des1 refers to insulin-like growth factor 1 or somattomedin C. This is a protein that has been encoded as the IGF1 gene when it appears in a natural setting. It is also often referred to as a sulfation factor which causes non-suppressible insulin-like activity when it is activated.

In a natural setting, this hormone mimics the structure of insulin. The synthetic version of this chemical is used as a mecasermin that may have factors that could be used to treat growth failure, though studies are still ongoing regarding the potential application of this synthetic chemical in a natural setting.

Mechanism of Action

The natural version of Igf-1 des-1 exists in a variety of types of tissues and cells.

  • When this chemical binds to IGF1R it creates a receptor tyrosine kinase which initiates intracellular signaling. The Igf-1 des1 chemical is one of the most potent activators within the AKT signaling pathway, stimulating proliferation and cell growth while inhibiting programmed cell death.
  • Once Igf-1 is produced in the body, it will affect every type of cell, particularly the nerve cells, while stimulating DNA synthesis.

The synthetic version of this chemical is largely designed to mimic these effects on tissues. Researchers hope that in time this synthetic chemical can be developed to a point where it could be used to treat deficiencies of GH in the animal body. Currently the synthetic version is applied to cattle to increase reproductive performance.

The protien Igf-1 Des1

Effects on Diet

Igf-1 des1 was studied to determine how it affects the quality and quantity of dietary proteins within plasma immunoreactive insulin in the livers of rats.

  • Plasma immunoreactive concentrations of Igf-1 were found to be higher in rats that followed a casein diet rather than those that followed a protein-free diet consisting of soya-bean proteins.
  • Throughout the study, four species of the Igf-1 hormone were found to have a different molecular weight when stored in the liver of the rat. Those on a gluten diet were found to have a decrease in the size of the chemicals in the liver compared to those on the casein diet.
  • The livers of the rats that were given the gluten, protein-free diet were around .4 compared to the rats that followed the casein diet.

It was found that applying a soya-bean protein diet to the rats did not have a marked effect on the mRNA version of Igf-1. This indicates that this version of the chemical and its sensitivity may be regulated by the nutritional quantity and quality of the dietary proteins in the system.

In more recent studies, a plant expression of Igf-1 des1 was developed in a transgenic rice grain that could produce the chemical in a recombinant natural setting, but additional study is needed to best determine the proper way to manufacture this version of the chemical.

Sources

http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=870596

 

Click here to view the homepage of our store

Click here to view our entire PDF research library

Click here to view or download this article in PDF format

Insulin Growth Factors

(Click here to read our disclaimer)

(Click here to view this product in our store)

Insulin growth factors are the proteins that have sequence similarities to insulin. They are used to allow cells to communicate with the physiologic environment, a system commonly referred to as the IGF axis. In most animals, this hormone is secreted by the liver when it is stimulated.

If insulin growth factors are not secreted properly in animals, it can lead to a variety of diseases including cancers. When the hormone is functioning properly, it can stimulate proliferation of cells while inhibiting cell death.

The effects vary throughout the animal body because many different tissues will be affected by insulin growth factors. At high concentrations this chemical can activate insulin receptors to compliment the natural effects of insulin.

Insulin Growth Factors

Diseases that May affect Insulin Growth Factors in the Body

Recent studies imply that the healthy presence of insulin growth factors in the body of animals may have an important role in the aging process.

  • Studies using fruit flies and nematodes were used to determine how a life span could be increased when the gene that was the equivalent of what would produce insulin in mammals was knocked out.
  • These results were somewhat inconclusive as the studies focused on small organisms which had several genes that would mimic those of insulin growth factors in mammals.
  • These results were further complicated because mammals typically have a specific organ designated for the creation of insulin while other organisms did not.

While study results were inconclusive, these examinations determined that the absence of insulin growth factors could perturb aging. It is also shown that restricting the diet, which would impact insulin us,e would impact this status.

Effects on RNA Expression in Middle-Aged Rats

The activity of insulin-like receptors DAF-2 and reproductive growth was monitored during the adult life span of rats to better understand how insulin growth factors functioned in mammals.

  • Analysis revealed that 37 C. genes could be used to predict and incode insulin-like peptides. Many of these insulin genes are within the same superfamily and were clustered–which indicates that the diversification of this family is fairly recent.
  • These genes are largely expressed in neurons such as sensory neurons which are required for reproductive development. The predictions of these structures at cleavage sites indicate that the insulin receptors ins-1 are more closely related to insulin in mammals than they are in other animals.
  • In these types of animals, this implies that the penetrant arrest of these chemicals at the dauer state can enhance the weak daf-2 mutants, which implies that ins-s can be used to antagonize these receptors to signal inulin.

The coding regions for these genes implies that there is a redundancy as only one other ins gene can be used as a predicted C peptide for signaling das-2, but four of the genes do not. This indicated that there is still functional diversity within this gene family.

The specific effects of insulin growth factors in a variety of animals and how isolating or eliminating genes within these animals is expanding the understanding of how these chemicals function. However, additional study is necessary to determine how these methods could be applied to mammals.

Source:

http://www.ncbi.nlm.nih.gov/pubmed/9483550

Click here to view the homepage of our store

Click here to view our entire PDF research library

Click here to view or download this article in PDF format

Ipamorelin And Bone Mineral Content

(Click here to read our disclaimer)

buy ipamorelinIpamorelin is a chemical name that refers to CJC-1295. There are a number of cells that can be affected by this chemical which typically results in large secretions of hormones in animals when it is applied.

In studies, ipamorelin is commonly used in research environments, because it is more stable than comparable chemicals such as sermorelin. In some cases, this chemical has been used on animals to study potential uses as a melanotan injection.

This version of the chemical binds with the melanocortin receptors in an animal’s skin which could increase inflammation, energy, pigmentation of the skin, sexual function or appetite. Studies of the usefulness or application of these effects in a natural setting are ongoing.

Uses in Increasing Bone Mineral Content

Female rats were used in a recent experiment to showcase the vitality of hormones in normal bone remodeling.

  • The study indicated that increasing a certain class of hormone secretagogues would in turn increase the concentrations of biochemical markers that were necessary for the formation of bone. The goal was to determine whether chemicals such as GHRP-6 or ipamorelin could potentially be used to improve bone mineral content in these rats.
  • Female rats 13 weeks old were exposed to either chemical via osmotic minipumps for a total of 12 weeks. They were then monitored with dual X-ray absorptiometry every four weeks.
  • After the study was completed, the rats were killed to examine the femurs via vitro mid-diaphyseal pQCT scans. The femurs and vertebrae L6 to determine the ash weights.

All applied chemicals were found to increase the body weight of rats and the vertebral and tibial BMC compared to those with vehicle-treated control settings. The pQCT measurements revealed that the cortical BMC increased in the cross-sectional bone area while the cortical volumetric BMD did not change.

Efficacy in Rodent Model Postoperative Ileus

Studies have attempted to investigate whether or not ipamorelin could accelerate the gastrointestinal transit or ameliorate symptoms in a rodent postoperative ileus.

  • Male rats were fasted and then given an intestinal manipulation and laparotomy. After the surgery, dye markers were applied to the proximal colon to better evaluate postsurgical colonic transit time or the time it took to reach the first bowel movement.
  • The food intake, body weight and pellet output were also regularly monitored throughout the course of the study.
  • The rats were either exposed to GHRP-6, a saline vehicle or ipamorelin via intravenous bolus infusion either in one or two doses per day.

This study indicated that ipamorelin would decrease the time of the first bowel movement, but would have no effect on the body weight of the rat, cumulative fecal output or food intake.

However, repeated doses of ipamorelin had a significant impact on the cumulative body weight gain, pellet output and food intake in the rats, implying that applying ipamorelin in postsurgical settings could help to ameliorate symptoms in those with POI.

Versions of ipamorelin used for increasing the secretions of hormones, versus those used to increase the reaction of melanocrotin receptors, have a small variance in amino acid structures.

Sources:

http://www.ncbi.nlm.nih.gov/pubmed/10828840

http://www.ncbi.nlm.nih.gov/pubmed/19289567

 

Click here to view the homepage of our store

Click here to view our entire PDF research library

Click here to view or download this article in PDF format